Skip to main content
. Author manuscript; available in PMC: 2010 Jul 7.
Published in final edited form as: J Pediatr Rehabil Med. 2010 Apr 19;3(1):13–23.

Fig. 2.

Fig. 2

Individual data for volumetric bone mineral density (vBMD) Z-score of the spine by QCT in 6 subjects with MPS VI on Enzyme replacement therapy at either 1.0 mg/kg/wk (Solid line) or 0.2 mg/kg/wk (Dashed line). Low bone mass, defined as Z-score < −2.0, observed in only one subject at 144 weeks. Patient #50 withdrew from the study at week 32.